16
Trusted evidence. Informed decisions. Better health. The Cochrane Tobacco Addiction Group at 20: ensuring our evidence is relevant Dr Nicola Lindson-Hawley Managing Editor Cochrane Tobacco Addiction Group Nuffield Department of Primary Care Health Sciences, University of Oxford @cochraneTAG Evidence Live 2016: Thursday 23 rd June

Evidence Live 2016 CTAG taps slides

Embed Size (px)

Citation preview

Page 1: Evidence Live 2016 CTAG taps slides

Trusted evidence.Informed decisions.Better health.

The Cochrane Tobacco Addiction Group at 20:

ensuring our evidence is relevant

Dr Nicola Lindson-Hawley

Managing EditorCochrane Tobacco Addiction GroupNuffield Department of Primary Care Health Sciences, University of Oxford

@cochraneTAG

Evidence Live 2016: Thursday 23rd June

Page 2: Evidence Live 2016 CTAG taps slides

One of 53 topic specific, worldwide Cochrane Review Groups

Carry out and manage high quality systematic reviews of interventions for tobacco use & prevention

Over 90 reviews & 350 authors

Not-for-profit- National Institute for Health Research (NIHR) funded

Established 1996. 2016 is our 20th anniversary!

Cochrane Tobacco Addiction Group (CTAG)

Page 3: Evidence Live 2016 CTAG taps slides

CTAG’s aims To inform tobacco control policy

internationally

to inform research in tobacco control, and help ensure new research is focussed on important unanswered questions

to contribute to reducing tobacco use

Page 4: Evidence Live 2016 CTAG taps slides

Cochrane Tobacco Addiction Group (CTAG) Editorial base at the Nuffield Department of Primary Care Health Sciences, University

of Oxford

Jamie Hartmann-Boyce Managing Editor

Nicola Lindson-HawleyManaging Editor

Lindsay SteadManaging Editor &

Information Specialist

Tim LancasterCo-ordinating Editor

Paul AveyardEditor, University of Oxford

Robert WestEditor, UCL

John HughesEditor, University of Vermont

Page 5: Evidence Live 2016 CTAG taps slides

The Cochrane TAG 20th anniversary priority setting project (CTAG taps) Developed by members of CTAG and departmental Communications

Manager

Funded by the NIHR School for Primary Care Research

AIMS

1. Raise awareness of the group, and what we have achieved so far

2. Identify areas where further research is needed in the areas of tobacco control & smoking cessation by involving our stakeholders

3. Identify specific goals for Cochrane TAG

Page 6: Evidence Live 2016 CTAG taps slides

Involving our stakeholders Until now CTAGs work has mainly been

informed by researchers

Including others in decisions about future directions will enable findings to: 1) be better applied to those who need them; and 2) have a higher global impact

Inspired by the work of the James Lind Alliance

Some of CTAG’s stakeholders:

Policy makers

Research fundersResearchers

Healthcare providers

Current & former smokers

Healthcare commissioners

Page 7: Evidence Live 2016 CTAG taps slides

Methods

Developed survey asking respondents to share a max. of 4 questions they would like to see answered by tobacco control research in general

Aimed at anyone with an interest in tobacco (personal or professional)

presented to Nottingham smoker’s panel – adjusted in response to comments

Built in Survey Monkey and accessed via internet link

Disseminated link via mailing lists, contacting public health organisations, Twitter, Facebook, conferences, blogging

Survey stage 1: Identifying uncertainties

Page 8: Evidence Live 2016 CTAG taps slides

Survey stage 1: Identifying uncertaintiesResults

Removed duplicates from submitted questions leaving 258

15 were non-empirical questions

60 already answered - more effective dissemination needed?

183 unanswered questions identified

All these decisions were made by at least 2 people independently

What smoking quit rates do

Quitlines result in?

What are the health effects of waterpipe use?

Page 9: Evidence Live 2016 CTAG taps slides

Research categories

Addressing inequalities Nicotine and tobacco risk

Alternative tobacco products Population level interventions

Digital interventions Pregnancy

E-cigarettes Smoking bans and second-hand smoke

Illness & chronic disease sufferers Smoking treatment methods excluding medications

Initiating quit attempts Treatment delivery

Medications Young people

Mental health and other substance abuse

Our uncertainties were classified into 15 research categories, containing 3-21 questions each

Page 10: Evidence Live 2016 CTAG taps slides

Methods

Survey developed asking respondents to:

1. rank the 15 research categories identified in Stage 1 in order of importance (prioritisation): 1= most important; 15= least important

2. Rank the questions within their top 3 categories (1=most important)

Again, checked by member of the public,

Built in Survey Monkey, accessed via link

Sent out to the 278 stage 1 respondents who provided full contact details via email

Opportunity to win 1 of 3 Amazon vouchers

Survey stage 2: Ranking uncertainties

Page 11: Evidence Live 2016 CTAG taps slides

Survey stage 2: Ranking uncertainties 175 people completed the survey (63% of those invited)

Total ranks for each category/question were added together. Total scores were ordered within their set and given an overall rank

Page 12: Evidence Live 2016 CTAG taps slides

Built on survey findings but focused more specifically on prioritisation for Cochrane TAG

Where CTAG should focus its future efforts and ways to disseminate findings

Practical workshop session designed and led by independent facilitation company- Hopkin van Mil

Stage 3: Prioritisation Workshop

Page 13: Evidence Live 2016 CTAG taps slides

Setting the scene

Page 14: Evidence Live 2016 CTAG taps slides

Prioritising CTAG research & dissemination

Page 15: Evidence Live 2016 CTAG taps slides

Analyse workshop data: flip charts, audio recordings, delegate notes

Write-up as a report for publication in a scientific journal

Develop new review dissemination plan

Present the results at international conferences

Use findings to set CTAG priority list

Begin working on priorities by the end of 2016

Next steps

Page 16: Evidence Live 2016 CTAG taps slides

How to find out more or contact us Visit our website: http://tobacco.cochrane.org/

Tweet us: @cochraneTAG

Email us: [email protected]

Call us: +44 (0)1865 289 320

National Institute for Health Research School for Primary Care Research (NIHR SPCR) is a partnership between the Universities of Bristol, Cambridge, Keele, Manchester, Newcastle, Nottingham, Oxford, Southampton and University College London. This presentation summarises independent research funded by the National Institute for Health Research School for Primary Care Research. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.